Hum. Reprod. Advance Access originally published online on July 30, 2007
Human Reproduction 2007 22(10):2577-2584; doi:10.1093/humrep/dem246
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
OPINION |
Tubal ectopic pregnancy: macrophages under the microscope
1 Laboratorio di Analisi, Ospedale Mater Salutis, via C. Gianella, 1-37045 Legnago, Verona, Italy 2 Istituto di Chimica e Microscopia Clinica, Dipartimento di Scienze Morfologico-Biomediche, Ospedale Policlinico G.B. Rossi, Verona, Italy
3 Correspondence address. Tel: +39-442-632264; Fax: +39-442-632323; E-mail: a_tonello{at}yahoo.it
| Abstract |
|---|
|
|
|---|
BACKGROUND: Ectopic pregnancy (EP) is a major reproductive health issue, whose underlying causes remain largely unknown. The unusual macrophage presence in the oviduct affected by EP could indicate macrophage contribution to the pathology.
METHODS: Macrophages have important functions in reproduction that are reviewed in this work. They are needed for tissue remodelling and immune-regulatory roles, and are present both in the ovary and uterus. Numerous cytokines regulate monocytes recruitment, differentiation and function in the reproductive tract, among them leukaemia inhibitory factor (LIF), colony-stimulating factor 1 and transforming growth factor-
are indispensable and non-redundant for reproductive outcome. Cytokine types and levels are modulated by estrogen, progesterone and seminal plasma, which drive the differentiation of monocytes to immunity cells or to immunosuppressed trophic and scavenging macrophages.
RESULTS: Many risk factors for EP involve an inflammatory reaction that can induce the release of mononuclear phagocytes from the bone marrow and/or favour immunosuppressed trophic differentiation of newly recruited mononuclear phagocytes in the reproductive tract. These observations strengthen the hypothesis that immunosuppressed trophic and scavenging macrophages may have a role in EP onset.
CONCLUSIONS: Macrophages may contribute to the regulation of tubal motility through prostaglandin production and induction of progesterone secretion. Considerations about LIF also suggest that macrophages may have a central role in ectopic receptivity.
Key words: ectopic pregnancy/estrogen/Fallopian tube/macrophage/progesterone
| Introduction |
|---|
|
|
|---|
Ectopic pregnancy (EP) is a life and fertility threatening event, which occurs in 1.3–2% of all reported pregnancies in the western world (Farquhar, 2005
Looking for possible alterations predisposing to EP, we compared the ectopic tube to the normal tube and to the endometrial stroma. The stroma compartment of the human endometrium has been extensively studied, both during the menstrual cycle and in pregnancy. Besides fibroblasts, leukocytes represent an important fraction of decidual cells. In the first trimester of pregnancy, 30% of cells in the decidual stroma are leukocytes, of which 20–30% are macrophages (Bulmer, 1995
). The major contributors to the leukocyte infiltrate are the CD56 + NK cells, which account for up to 70% of the leukocyte population in the first trimester decidua (Bulmer, 1995
). In EP, the distribution patterns of macrophages, T cells and B cells found in tubal implantation sites are similar to those found in normal intrauterine implantation sites (von Rango et al., 2001
). In EP, macrophages and T lymphocytes form the predominant leukocyte subpopulation both in the tubal implantation site and in the tubal mucosa away from the implantation site (Vassiliadou and Bulmer, 1998a
,b
), but CD56 + cells are never present in the tubal mucosa, although they are always present in conspicuous fractions in intrauterine decidual tissue (Vassiliadou and Bulmer, 1998a
,b
; von Rango et al., 2001
). Significantly fewer leukocytes are found within the tubal mucosa during the normal menstrual cycle than in the tubal wall distant from the implantation site in tubal EP. The macrophage density is more than doubled in EP and it is mainly responsible for the difference in the number of leukocytes (von Rango et al., 2001
). Is this finding the sign of an involvement of macrophages in EP development? To test this hypothesis, we reviewed the literature regarding these cells in reproduction. We paid special attention to the effects exerted on macrophages by cytokines such as leukaemia inhibitory factor (LIF), colony-stimulating factor 1 (CSF-1) and transforming growth factor (TGF-
), which are essential and non-redundant for reproductive outcome, as highlighted by targeted gene disruption (Makrigiannakis et al., 2006
). Interleukin (IL)-11, the other cytokine identified as indispensable for reproduction, can also modulate macrophage activation (Schwertschlag et al., 1999
) and is expressed in EP (von Rango et al., 2004
) but, to date, knowledge on its functions in implantation is only at a preliminary level, so we will make no more mention of it.
Macrophages carry out tissue remodelling functions and immune-regulatory roles in the reproductive tract. EP risk factors can alter their recruitment and/or differentiation programmes and evidence will be presented that macrophages are appealing candidates for at least a partial and perhaps prominent causal role in the development of EP.
| Macrophage roles in reproduction |
|---|
|
|
|---|
Macrophages are important accessory cells for reproductive functions and are found abundantly in the reproductive tract of both males and females (Cohen et al., 1999
In the adult uterine stroma, macrophages undergo dramatic fluctuations in response to the changing hormonal milieu (Hunt and Robertson, 1996
; Cohen et al., 1999
). In mice, their density is lowest at diestrus during periods of relative estrogen depletion and increases to
20% of the stromal cells at proestrus, under the influence of estrogen (Hunt and Robertson, 1996
; De and Wood, 1990
). Cyclic changes in the number of endometrial macrophages are also a feature of the human menstrual cycle. Macrophages increase by
45% between the proliferative and early secretory stages (Bulmer, 1995
). Unlike the situation in rodents, where macrophage density declines as the cycle reaches completion, the number of these cells continues to increase in the late secretory stages of the menstrual cycle. These differences may relate to the absence (rodent) or presence (women) of endometrial shedding and repair, processes where macrophages would be useful (Hunt and Robertson, 1996
).
Epithelial cells in mouse uteri respond to signals from ovarian steroid hormones by producing an array of cytokines that are known to regulate macrophage recruitment, survival, differentiation and/or function (Robertson et al., 1994
). These include CSF-1, granulocyte-macrophage colony-stimulating factor (GM-CSF), tumour necrosis factor-
(TNF-
) and IL-6. In mouse uterine epithelial cells, synthesis of CSF-1 is stimulated by estrogen and progesterone, whereas GM-CSF is stimulated by estrogen and moderately inhibited by progesterone (Robertson et al., 1996
). Following mating, the macrophage uterine population is sustained (Robertson et al., 1997
), and during pregnancy, it increases in density compared with other types of uterine cells. This has been demonstrated in mouse, rat and human uteri (Bulmer, 1995
; Hunt and Robertson, 1996
).
LIF, a member of the IL-6 family, is a highly glycosylated 40–50 kDa glycoprotein with a broad range of biological functions (Haines et al., 2000
). LIF signalling in the endometrium is essential for embryo implantation, whereas embryos lacking components of the LIF receptor complex will implant normally (Stewart et al., 1992
; Song et al., 2000
). LIF exerts at least some of its functions by means of macrophages. Comparison of LIF knockout and wild-type mice suggests that LIF has a greater effect on leukocyte dynamics and distribution. The percentage of macrophages is reduced by more than half in the LIF knockout mice on day 3 of pregnancy, and their distribution is disrupted, suggesting that LIF is a chemokine for these cells (Schofield and Kimber, 2005
). LIF has been shown to be a chemoattractant for macrophages in other tissues, such as in the nervous system, where it works in conjunction with other chemokines, such as IL-6 and oncostatin M, to recruit macrophages (Tofaris et al., 2002
). LIF can also induce macrophage maturation (Hilton et al., 1988
; Laabi et al., 2000
).
CSF-1 functions in reproduction
The CSF-1-null mutant mouse has severely depleted macrophage populations in many tissues (Pollard and Stanley, 1996
). It is interesting that the study of macrophage populations suggests that the tissue density of those macrophages that have scavenging/trophic roles is dramatically affected by the absence of CSF-1, whereas those that populate immune organs are relatively less affected (Pollard and Stanley, 1996
). Analysis of mice that are deficient for macrophages and other mononuclear phagocytic cells (such as osteoclasts) because of a null mutation in CSF-1 shows that these cells have a significant role in the morphogenesis of many tissues (Pollard and Stanley, 1996
; Pollard, 1997
). Developmental defects include osteopetrosis, dermal hypoplasia, aberrant development of the sex-steroid-hormone feedback response in the brain, delayed and aberrant pancreatic morphogenesis and impaired branched morphogenesis of the mammary gland.
In the CSF-1 deficient mouse, low-pregnancy rates and smaller litter sizes are observed compared with the wild-type mouse (Pollard et al., 1991
). The major effects of CSF-1 deficiency on the female reproductive function are disrupted estrous cycle and lower-ovulation rate (Cohen et al., 1997
). The receptor for CSF-1, the product of the c-fms proto-oncogene (Sherr et al., 1985
), is a transmembrane tyrosine kinase and is detected in oocytes, preimplantation embryos, ovarian and uterine macrophages, decidual cells and trophoblasts (Cohen et al., 1997
). In mice and humans, CSF-1 mRNA can be detected in granulosa cells as the follicle matures and at least in humans, the CSF-1 concentration of follicular fluid is significantly higher than the serum (Witt and Pollard, 1997
). Since CSF-1 is a chemoattractant for macrophages (Webb et al., 1996
), it seems probable that the follicle-synthesized CSF-1 plays at least a part in the recruitment of macrophages proximate to the developing follicle. As the corpus luteum matures after copulation, the number of macrophages in CSF-1 deficient mice increases until it reaches
35% of the wild-type number (Cohen et al., 1997
). This strongly suggests the presence of another macrophage chemoattractant synthesized by the luteal cells.
CSF-1 is produced by the uterine epithelium in response to female sex steroid hormones (Pollard et al., 1987
) and studies with CSF-1 deficient mice have shown that CSF-1 is a key regulator of the uterine stromal macrophage population, because their numbers are very substantially reduced in such mice (Pollard et al., 1998
). In humans, there is increased local production of CSF-1 in tissues found at the maternal-fetal interface during the time of implantation (Kauma et al., 1991
) and CSF-1 production continues in the uterine epithelium during pregnancy (Pollard et al., 1987
; Arceci et al., 1989
; Daiter et al., 1992
). Moreover, decidual T cell clones from women suffering from unexplained recurrent abortion display decreased production of CSF-1, as well as of other cytokines, including LIF (Piccinni et al., 2001
).
| Seminal plasma and maternal immunotolerance |
|---|
|
|
|---|
Artificial insemination in livestock species, which often involves extensive dilution of seminal plasma (SP), results in fertility and fecundity rates which are generally lower than those of natural matings (O'Leary et al., 2006
The post-mating inflammatory response in pigs is transient and by the time the embryo implants it has dissipated, but altered expression patterns of SP induced factors persist during the pre-implantation period (O'Leary et al., 2004
). The active component in SP has been identified as TGF-
(Tremellen et al., 1998
), a cytokine present in abundance in the SP of all mammalian species so far examined (Robertson et al., 2002
). Besides tissue remodelling functions, immune-regulatory roles for inflammatory leukocytes have been proposed. Activation of T lymphocytes in draining lymph nodes after mating is consistent with an immune response to antigens in semen (Johansson et al., 2004
), potentially facilitating maternal immunotolerance to the conceptus at implantation (Robertson and Sharkey, 2001
). The high TGF-
content confers potent immunosuppressive activity to SP (Robertson et al., 2002
). TGF-
suppresses dendritic cell (DC) maturation and function, and favours the differentiation of regulatory T cells, characterized by high expression of TGF-
and IL-10 as well. Regulatory T cells can functionally suppress an immune response by influencing the activity of another cell type; they are key mediators of peripheral and mucosal T-cell tolerance (Weiner, 2001
; Shevach, 2004
). In human semen, there is also an abundance of prostaglandin E2 (PGE2), which is undetectable in rodent and porcine SP (Denison et al., 1999a
,b
; Robertson et al., 2002
). PGE2 contributes to the suppression of DC differentiation and function through its capacity to inhibit IL-12 synthesis (Kalinski et al., 1999
; Sombroek et al., 2002
). The immune deviating effects of seminal cytokines in the female tract can be amplified by locally synthesized TGF-
and PGE2, as well as additional deviating cytokines IL-4, IL-6 and IL-10, secreted from endocervical and endometrial cells in women (Fichorova and Anderson, 1999
) and in rodents (Tamada et al., 1990
). In the case of IL-10 and IL-6, expression is inducible by seminal factors (Robertson et al., 1992
; Denison et al., 1999a
,b
).
In mice, the inflammatory response elicited by SP terminates in association with rising progesterone levels (Robertson et al., 1996
). Progesterone, the dominant hormone of mammalian pregnancy, profoundly influences immune cells and directs them into a generally suppressive profile (Pepe and Albrecht, 1995
). For example, progesterone enhances PGE2 production by human placental macrophages (Yagel et al., 1987
). PGE2 acts as an autocrine inhibitor for macrophages, in which it suppresses TNF-
production (Kunkel et al., 1988
).
| Trophic differentiation of macrophages |
|---|
|
|
|---|
The macrophage population may be subdivided in two main groups according to different functions and regulation (Pollard and Stanley, 1996
, IL-10, PGE2 and vascular endothelial growth factor (VEGF) are all immunosuppressive factors with important functions in reproduction. The cytokines that direct macrophages towards more cytotoxic and antigen-presenting phenotypes are GM-CSF, interferon-
(IFN-
), IL-4 and IL-12 (Dranoff, 2004
|
| Macrophage involvement in EP |
|---|
|
|
|---|
In 35–50% of the patients, the main predisposing condition for EP is pelvic inflammatory disease (PID) with salpingitis (Ankum et al., 1996
Tubal surgery, sterilization and previous EP are high risk factors (Farquhar, 2005
): they cause tissue damage and elicit an inflammatory response that attracts macrophages for wound healing. Besides inflammatory stimuli, which induce release of mononuclear phagocytes from bone marrow and tubal recruitment of macrophages, disturbances to the fine-tuning between immunity and immunotolerance may also play a role in EP development. Many risk factors for EP can favour an unbalanced production of CSF-1 over GM-CSF, thus driving trophic differentiation of newly recruited mononuclear phagocytes (Fig. 1). There is a higher incidence of EP after contraceptive failure in women who had taken progestin-only oral contraceptives or had progestin-only implants compared with pregnant women in the general population (Furlong, 2002
), suggesting a role for the immunosuppressive activity of progesterone in EP onset. Having more than one sexual partner, another recognized risk factor for EP (Farquhar, 2005
), provokes multiple inflammatory stimuli, in order to achieve immunotolerance to all the possible paternal antigens, so it may increase macrophage recruitment compared with monogamy and also enhance the maximal level of progesterone synthesis. Infections favour macrophage recruitment, but stimulate the production of factors, such as TNF
, GM-CSF and IFN
, that direct macrophages towards cytotoxic and antigen-presenting phenotypes. This could be the reason why tubal infections are associated with a lower risk of EP compared with tubal surgery (Ankum et al., 1996
) and smoking (Hillis et al., 1997
), which elicit macrophage activation without immunogenic stimuli and direct them towards trophic functions. If we consider smoking as a risk factor, we can suppose that every inflammatory event that induces the release of mononuclear phagocytes from bone marrow may contribute to the recruitment of macrophages in the reproductive tract, even if its location is far away from the müllerian system. Indeed, the localization process of inflammatory cells is not particularly efficient and many of the cells released from the marrow in the circulation actually become distributed to other locations of no obvious relevance to the inflammatory response (Metcalf et al., 1996
).
All the above mentioned risk factors can be associated with stimulation of macrophage production and/or trophic differentiation, and this reinforces macrophage involvement in EP onset and suggests that macrophages may have undervalued functions in the control of tubal motility and/or in the process of blastocyst implantation.
| Discussion |
|---|
|
|
|---|
The development of an EP has never been observed, owing to the lack of animal models, and studies on EP only investigate the pathology after the implantation has occurred. Numerous studies show that there are no differences in the abundance of macrophages between uterine and tubal implantation sites (Vassiliadou and Bulmer, 1998a
Analysis of risk factors emerging from epidemiological studies gives an important sign of macrophage involvement in EP. Genital tract infections with chronic salpingitis result in the diffuse and persistent distribution of macrophages throughout the Fallopian tube. High risk factors, which include tubal surgery, sterilization and previous EP (Farquhar, 2005
), cause tissue damage that elicits an inflammatory response and attracts macrophages to get wound healing. Mononuclear phagocytes migrate from the venous system to the site of tissue injury, guided to the site by chemotactic factors. Once present, they differentiate into mature trophic and scavenging macrophages or immature dendritic cells (Osusky et al., 1997
). Activated macrophages are the main source of growth factors and cytokines [TGF-
, VEGF, platelet derived growth factor (PDGF), basic fibroblast growth factor (bFGF), TNF-
, IL-1, etc.] that modulate tissue repair (Coussens and Werb, 2002
). Many of these factors have important roles in uterine decidualization as well (Dey et al., 2004
). Another recognized risk factor for EP is smoking, which provokes exposition to chemical irritants that elicit non-immunogenic inflammatory stimuli, and drive immunosuppressed trophic differentiation of macrophages, as also happens in pulmonary alveoli, so as to prevent aberrant immune responses to harmless environmental agents (Bilyk and Holt, 1993
; Strickland et al., 1996
). It is demonstrated that smoke effects extend to the entire organism. Smoke action on macrophages may explain the surprising observation that pelvic infections contribute less to EP risk than does smoking.
What role might macrophages have in EP onset? An EP develops when blastocyst is trapped in the Fallopian tube and implants. Therefore, an altered tubal motility and a tubal propensity to receptivity are two necessary conditions for EP onset. Macrophages could take part in both processes. As to tubal motility, it is influenced by progesterone, estrogen and prostaglandins (Arbab et al., 2002
), with progesterone and prostaglandins causing smooth muscle relaxation (Roblero and Garavagno, 1979
; Arbab et al., 2002
) and high levels of progesterone causing ciliary dysfunction (Paltieli et al., 2000
). Activated macrophages increase progesterone secretion by granulosa and luteal cells (Halme et al., 1985
) and in turn progesterone enhances PGE2 production by macrophages (Yagel et al., 1987
). Thereafter, we can surmise that, in presence of an elevated number of macrophages, the concentration of progesterone and prostaglandins would be enough to impair tubal motility and cause embryo retention in the oviduct.
Considerations about LIF give some suggestions about tubal receptivity. In the process of uterine implantation, maternal LIF is essential. The percentage of macrophages is reduced by more than half in LIF-null mice on day 3 of pregnancy and their distribution is also altered, suggesting that LIF is a chemokine for these cells (Schofield and Kimber, 2005
). However, by day 4, macrophage density appears similar to that in the wild-type mice. CD56 + NK cells are detected as early as day 3 of pregnancy in wild-type and LIF-null mice, but the LIF knockout uteri have double the wild-type percentage of NK cells at day 3. So it is possible that LIF restricts migration of NK cells into the uterus. Keltz et al. (1996) observed that LIF is expressed in the human oviduct without significant variation during the menstrual cycle. Epithelial cells secrete higher levels of LIF compared with stromal cells. Yet the treatment of tubal stromal cells with the inflammatory cytokines IL-1
and TNF-
and with the growth factors TGF-
, endothelial growth factor (EGF) and PDGF induces a striking enhancement of LIF expression and secretion. Hence a tubal inflammatory process may increase LIF production by oviducts and LIF may contribute to the recruitment of trophic macrophages. The presence of trophic macrophages and the absence of NK cells could predispose to the onset of EP. Macrophages could be necessary for the tissue remodelling needed for the blastocyst to infiltrate the stroma. Then the absence of CD56 + uterine NK cells could permit trophoblast cells to invade deeply into the tubal wall. It is interesting to note that LIF mRNA levels are higher in the isthmic segment of the Fallopian tube when associated with an EP compared with that in normal tubes from non-pregnant subjects (Keltz et al., 1996
). Moreover, there is a higher level of LIF in perimenopausal tubes in women between ages 47 and 53 years (Keltz et al., 1996
). This enhanced production of LIF could augment macrophage recruitment in the oviduct and contribute to the higher incidence of EP with aging.
| Conclusion |
|---|
|
|
|---|
Current knowledge on reproduction cannot explain the cellular and molecular mechanisms causing blastocyst ectopic implantation and animal models are missing. Our attention was attracted from macrophages that are present in the ectopic tube and have important tissue remodelling and immune-regulatory roles in reproduction. Evidences are presented that proper recruitment and differentiation of macrophages might be crucial for the reproductive outcome. Factors that perturb macrophage recruitment and differentiation might affect fertility and have effects both on tubal motility and propensity to receptivity. These observations may be significant not only for EP but also for normal uterine pregnancy as well. For example, the effect of high estrogen levels on macrophage differentiation may explain the poor pregnancy success rate in assisted reproduction (about 30%), due to the transfer of IVF-derived embryos into non-receptive uteri (Dey et al., 2004
Overall, the data reviewed in this work suggest that macrophage involvement may be a good starting point for understanding how and why EP arises.
| References |
|---|
|
|
|---|
Ankum WM, Mol BW, Van der Veen F, Bossuyt PM. Risk factors for ectopic pregnancy: a meta-analysis. Fertil Steril (1996) 65:1093–1099.[Web of Science][Medline]
Arbab F, Goldsby J, Matijevic-Aleksic N, Huang G, Ruan K, Huang J. Prostacyclin is an autocrine regulator in the contraction of oviductal smooth muscle. Hum Reprod (2002) 17:3053–3059.
Arceci RJ, Shanahan F, Stanley ER, Pollard JW. Temporal expression and location of colony-stimulating factor 1 (csf-1) and its receptor in the female reproductive tract are consistent with csf-1-regulated placental development. Proc Natl Acad Sci USA (1989) 86:8818–8822.
Bilyk N, Holt PG. Inhibition of the immunosuppressive activity of resident pulmonary alveolar macrophages by granulocyte/macrophage colony-stimulating factor. J Exp Med (1993) 177:1773–1777.
Brannstrom M, Enskog A. Leukocyte networks and ovulation. J Reprod Immunol (2002) 57:47–60.[CrossRef][Web of Science][Medline]
Brannstrom M, Pascoe V, Norman RJ, McClure N. Localization of leukocyte subsets in the follicle wall and in the corpus luteum throughout the human menstrual cycle. Fertil Steril (1994) 61:488–495.[Web of Science][Medline]
Bulmer JN. Immunology of human reproduction. Kurpisz M, Fernandez N, eds. (1995) Oxford: Bios Scientific Publishers. 313–334.
Cohen PE, Zhu L, Pollard JW. Absence of colony stimulating factor-1 in osteopetrotic (csfmop/csfmop) mice disrupts estrous cycles and ovulation. Biol Reprod (1997) 56:110–118.[Abstract]
Cohen PE, Nishimura K, Zhu L, Pollard JW. Macrophages: important accessory cells for reproductive function. J Leukoc Biol (1999) 66:765–772.[Abstract]
Corpa JM. Ectopic pregnancy in animals and humans. Reproduction (2006) 131:631–640.
Coussens LM, Werb Z. Inflammation and cancer. Nature (2002) 420:860–867.[CrossRef][Medline]
Daiter E, Pampfer S, Yeung YG, Barad D, Stanley ER, Pollard JW. Expression of colony-stimulating factor-1 in the human uterus and placenta. J Clin Endocrinol Metab (1992) 74:850–858.[Abstract]
De M, Wood GW. Influence of oestrogen and progesterone on macrophage distribution in the mouse uterus. J Endocrinol (1990) 126:417–424.
Denison FC, Calder AA, Kelly RW. The action of prostaglandin E2 on the human cervix: stimulation of interleukin 8 and inhibition of secretory leukocyte protease inhibitor. Am J Obstet Gynecol (1999a) 180:614–620.[CrossRef][Web of Science][Medline]
Denison FC, Grant VE, Calder AA, Kelly RW. Seminal plasma components stimulate interleukin-8 and interleukin-10 release. Mol Hum Reprod (1999b) 5:220–226.
Dey SK, Lim H, Das SK, Reese J, Paria BC, Daikoku T, Wang H. Molecular cues to implantation. Endocr Rev (2004) 25:341–373.
Dranoff G. Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer (2004) 4:11–22.[CrossRef][Web of Science][Medline]
Farquhar CM. Ectopic pregnancy. Lancet (2005) 366:583–591.[CrossRef][Web of Science][Medline]
Fichorova RN, Anderson DJ. Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells. Biol Reprod (1999) 60:508–514.
Furlong L. Ectopic pregnancy risk when contraception fails. A review. J Reprod Med (2002) 47:881–885.[Web of Science][Medline]
Gangnuss S, Sutton-McDowall ML, Robertson SA, Armstrong DT. Seminal plasma regulates corpora lutea macrophage populations during early pregnancy in mice. Biol Reprod (2004) 71:1135–1141.
Haines BP, Voyle RB, Rathjen PD. Intracellular and extracellular leukemia inhibitory factor proteins have different cellular activities that are mediated by distinct protein motifs. Mol Biol Cell (2000) 11:1369–1383.
Halme J, Hammond MG, Syrop CH, Talbert LM. Peritoneal macrophages modulate human granulosa-luteal cell progesterone production. J Clin Endocrinol Metab (1985) 61:912–916.
Hillis SD, Owens LM, Marchbanks PA, Amsterdam LF, Mac Kenzie WR. Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. Am J Obstet Gynecol (1997) 176:103–107.[CrossRef][Web of Science][Medline]
Hilton DJ, Nicola NA, Metcalf D. Purification of a murine leukemia inhibitory factor from krebs ascites cells. Anal Biochem (1988) 173:359–367.[CrossRef][Web of Science][Medline]
Hunt JS, Robertson SA. Uterine macrophages and environmental programming for pregnancy success. J Reprod Immunol (1996) 32:1–25.[CrossRef][Web of Science][Medline]
Jasper MJ, Robertson SA, Van der Hoek KH, Bonello N, Brannstrom M, Norman RJ. Characterization of ovarian function in granulocyte-macrophage colony-stimulating factor-deficient mice. Biol Reprod (2000) 62:704–713.
Johansson M, Bromfield JJ, Jasper MJ, Robertson SA. Semen activates the female immune response during early pregnancy in mice. Immunology (2004) 112:290–300.[CrossRef][Web of Science][Medline]
Kalinski P, Hilkens CM, Wierenga EA, Kapsenberg ML. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol Today (1999) 20:561–567.[CrossRef][Web of Science][Medline]
Kauma SW, Aukerman SL, Eierman D, Turner T. Colony-stimulating factor-1 and c-fms expression in human endometrial tissues and placenta during the menstrual cycle and early pregnancy. J Clin Endocrinol Metab (1991) 73:746–751.
Keltz MD, Attar E, Buradagunta S, Olive DL, Kliman HJ, Arici A. Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in the human fallopian tube. Am J Obstet Gynecol (1996) 175:1611–1619.[CrossRef][Web of Science][Medline]
Kunkel SL, Spengler M, May MA, Spengler R, Larrick J, Remick D. Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem (1988) 263:5380–5384.
Laabi Y, Metcalf D, Mifsud S, Di Rago L. Differentiation commitment and regulator-specific granulocyte-macrophage maturation in a novel pro-B murine leukemic cell line. Leukemia (2000) 14:1785–1795.[CrossRef][Web of Science][Medline]
LaVerda D, Kalayoglu MV, Byrne GI. Chlamydial heat shock proteins and disease pathology: new paradigms for old problems? Infect Dis Obstet Gynecol (1999) 7:64–71.[CrossRef][Medline]
Makrigiannakis A, Minas V, Kalantaridou SN, Nikas G, Chrousos GP. Hormonal and cytokine regulation of early implantation. Trends Endocrinol Metab (2006) 17:178–185.[CrossRef][Web of Science][Medline]
Menetrier-Caux C, Montmain G, Dieu MC, Bain C, Favrot MC, Caux C, Blay JY. Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. Blood (1998) 92:4778–4791.
Metcalf D, Robb L, Dunn AR, Mifsud S, Di Rago L. Role of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in the development of an acute neutrophil inflammatory response in mice. Blood (1996) 88:3755–3764.
O'Leary S, Jasper MJ, Warnes GM, Armstrong DT, Robertson SA. Seminal plasma regulates endometrial cytokine expression, leukocyte recruitment and embryo development in the pig. Reproduction (2004) 128:237–247.
O'Leary S, Jasper MJ, Robertson SA, Armstrong DT. Seminal plasma regulates ovarian progesterone production, leukocyte recruitment and follicular cell responses in the pig. Reproduction (2006) 132:147–158.
Osusky R, Malik P, Ryan SJ. Retinal pigment epithelium cells promote the maturation of monocytes to macrophages in vitro. Ophthalmic Res (1997) 29:31–36.[Web of Science][Medline]
Paltieli Y, Eibschitz I, Ziskind G, Ohel G, Silbermann M, Weichselbaum A. High progesterone levels and ciliary dysfunction—a possible cause of ectopic pregnancy. J Assist Reprod Gen (2000) 17:103–106.[CrossRef][Web of Science][Medline]
Pandya IJ, Cohen J. The leukocytic reaction of the human uterine cervix to spermatozoa. Fertil Steril (1985) 43:417–421.[Web of Science][Medline]
Pepe GJ, Albrecht ED. Actions of placental and fetal adrenal steroid hormones in primate pregnancy. Endocr Rev (1995) 16:608–648.
Piccinni MP, Scaletti C, Vultaggio A, Maggi E, Romagnani S. Defective production of LIF, M-CSF and Th2-type cytokines by T cells at fetomaternal interface is associated with pregnancy loss. J Reprod Immunol (2001) 52:35–43.[CrossRef][Web of Science][Medline]
Pollard JW. Role of colony-stimulating factor-1 in reproduction and development. Mol Reprod Dev (1997) 46:54–61.[CrossRef][Web of Science][Medline]
Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer (2004) 4:71–78.[CrossRef][Web of Science][Medline]
Pollard JW, Stanley ER. Pleiotropic roles for CSF-1 in development defined by the mouse mutation osteopetrotic (op). Adv Dev Biochem (1996) 4:153–193.[CrossRef]
Pollard JW, Bartocci A, Arceci R, Orlofsky A, Ladner MB, Stanley ER. Apparent role of the macrophage growth factor, CSF-1, in placental development. Nature (1987) 330:484–486.[CrossRef][Medline]
Pollard JW, Hunt JS, Wiktor-Jedrzejczak W, Stanley ER. A pregnancy defect in the osteopetrotic (op/op) mouse demonstrates the requirement for CSF-1 in female fertility. Dev Biol (1991) 148:273–283.[CrossRef][Web of Science][Medline]
Pollard JW, Lin EY, Zhu L. Complexity in uterine macrophage responses to cytokines in mice. Biol Reprod (1998) 58:1469–1475.
von Rango U, Classen-Linke I, Kertschanska S, Kemp B, Beier HM. Effects of trophoblast invasion on the distribution of leukocytes in uterine and tubal implantation sites. Fertil Steril (2001) 76:116–124.[CrossRef][Web of Science][Medline]
von Rango U, Alfer J, Kertschanska S, Kemp B, Müller-Newen G, Heinrich PC, Beier HM, Classen-Linke I. Interleukin-11 expression: its significance in eutopic and ectopic human implantation. Mol Hum Reprod (2004) 10:783–792.
Robertson SA, Sharkey D. The role of semen in induction or maternal immune tolerance to pregnancy. Semin Immunol (2001) 13:243–254.[CrossRef][Web of Science][Medline]
Robertson SA, Mayrhofer G, Seamark RF. Uterine epithelial cells synthesize granulocyte-macrophage colony-stimulating factor and interleukin-6 in pregnant and nonpregnant mice. Biol Reprod (1992) 46:1069–1079.[Abstract]
Robertson SA, Seamark RF, Guilbert LJ, Wegmann TG. The role of cytokines in gestation. Crit Rev Immunol (1994) 14:239–292.[Web of Science][Medline]
Robertson SA, Mayrhofer G, Seamark RF. Ovarian steroid hormones regulate granulocyte-macrophage colony-stimulating factor synthesis by uterine epithelial cells in the mouse. Biol Reprod (1996) 54:183–196.[Abstract]
Robertson SA, Mau VJ, Hudson SN, Tremellen KP. Cytokine-leukocyte networks and the establishment of pregnancy. Am J Reprod Immunol (1997) 37:438–442.[Medline]
Robertson SA, Sharkey DJ, Tremellen KP, Danielsson KG. Semen elicits immunological changes in the human cervix. J Soc Gynecol Invest (2001) 9:228A.
Robertson SA, Ingman WV, O'Leary S, Sharkey DJ, Tremellen KP. Transforming growth factor beta--a mediator of immune deviation in seminal plasma. J Reprod Immunol (2002) 57:109–128.[CrossRef][Web of Science][Medline]
Roblero LS, Garavagno AC. Effect of oestradiol-17 beta and progesterone on oviductal transport and early development of mouse embryos. J Reprod Fertil (1979) 57:91–95.
Schofield G, Kimber SJ. Leukocyte subpopulations in the uteri of leukemia inhibitory factor knockout mice during early pregnancy. Biol Reprod (2005) 72:872–878.
Schwertschlag US, Trepicchio WL, Dykstra KH, Keith JC, Turner KJ, Dorner AJ. Haematopoietic immunomodulatory and epithelial effects of interleukin-11. Leukemia (1999) 13:1307–1315.[CrossRef][Web of Science][Medline]
Sherr CJ, Rettenmier CW, Sacca R, Roussel MF, Look AT, Stanley ER. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell (1985) 41:665–676.[CrossRef][Web of Science][Medline]
Shevach EM. Fatal attraction: tumors beckon regulatory T cells. Nat Med (2004) 10:900–901.[CrossRef][Web of Science][Medline]
Sombroek CC, Stam AGM, Masterson AJ, Lougheed SM, Schakel MJAG, Meijer CJLM, Pinedo HM, van den Eertwegh AJM, Scheper RJ, de Gruijl TD. Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation. J Immunol (2002) 168:4333–4343.
Song H, Lim H, Das SK, Paria BC, Dey SK. Dysregulation of EGF family of growth factors and COX-2 in the uterus during the preattachment and attachment reactions of the blastocyst with the luminal epithelium correlates with implantation failure in LIF-deficient mice. Mol Endocrinol (2000) 14:1147–1161.
Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, Abbondanzo SJ. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature (1992) 359:76–79.[CrossRef][Medline]
Strickland D, Kees UR, Holt PG. Regulation of T-cell activation in the lung: alveolar macrophages induce reversible T-cell anergy in vitro associated with inhibition of interleukin-2 receptor signal transduction. Immunology (1996) 87:250–258.[CrossRef][Web of Science][Medline]
Talbot P, Di Carlantonio G, Knoll M, Gomez C. Identification of cigarette smoke components that alter functioning of hamster (mesocricetus auratus) oviducts in vitro. Biol Reprod (1998) 58:1047–1053.
Tamada H, McMaster MT, Flanders KC, Andrews GK, Dey SK. Cell type-specific expression of transforming growth factor-beta 1 in the mouse uterus during the periimplantation period. Mol Endocrinol (1990) 4:965–972.
Tofaris GK, Patterson PH, Jessen KR, Mirsky R. Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF. J Neurosci (2002) 22:6696–6703.
Tremellen KP, Seamark RF, Robertson SA. Seminal transforming growth factor beta1 stimulates granulocyte-macrophage colony-stimulating factor production and inflammatory cell recruitment in the murine uterus. Biol Reprod (1998) 58:1217–1225.
Vassiliadou N, Bulmer JN. Characterization of tubal and decidual leukocyte populations in ectopic pregnancy: evidence that endometrial granulated lymphocytes are absent from the tubal implantation site. Fertil Steril (1998) 69:760–767.[CrossRef][Web of Science][Medline]
Wang H, Guo Y, Wang D, Kingsley PJ, Marnett LJ, Das SK, DuBois RN, Dey SK. Aberrant cannabinoid signaling impairs oviductal transport of embryos. Nat Med (2004) 10:1074–1080.[CrossRef][Web of Science][Medline]
Webb SE, Pollard JW, Jones GE. Direct observation and quantification of macrophage chemoattraction to the growth factor CSF-1. J Cell Sci (1996) 109:793–803.[Abstract]
Weiner HL. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev (2001) 182:207–214.[CrossRef][Web of Science][Medline]
Witt BR, Pollard JW. Colony stimulating factor-1 in human follicular fluid. Fertil Steril (1997) 68:259–264.[CrossRef][Web of Science][Medline]
Yagel S, Hurwitz A, Rosenn B, Keizer N. Progesterone enhancement of prostaglandin E2 production by fetal placental macrophages. Am J Reprod Immunol Microbiol (1987) 14:45–48.[Web of Science][Medline]
Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer (2005) 5:263–274.[CrossRef][Web of Science][Medline]
Submitted on March 28, 2007; resubmitted on May 25, 2007; accepted on June 29, 2007.
![]()
CiteULike
Connotea
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
